Diffuse Podocytopathy Associated With Semaglutide
We present 3 cases of biopsy-proven minimal change disease occurring in close temporal association with semaglutide (glucagon-like peptide 1 receptor agonists) exposure. The observed diffuse podocytopathy was associated with de novo formation of antinephrin antibodies in 2 of the 3 cases. All patien...
Saved in:
| Main Authors: | Rose Mary Attieh, Grant Kirby, Yang Yihe, Serena Bagnasco, Andrew A. Moses, Mahmoud Abdelaziz, Rimda Wanchoo, Samir Gautam, Astrid Weins, Kenar D. Jhaveri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-05-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2023.1383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Minimal Change Podocytopathy with Coexistent Thin Glomerular Basement Membrane following Exposure to Semaglutide
by: Karthik Kovvuru, et al.
Published: (2025-01-01) -
What’s new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
by: Astrid Weins, et al.
Published: (2025-07-01) -
WCN24-1759 A Rare Case of Light Chain Proximal Renal Tubulopathy with Lambda-Restricted Crystal Storing Histiocytosis
by: Samir Gautam, et al.
Published: (2024-04-01) -
WCN24-802 ALPORT SYNDROME WITH PODOCYTOPATHY
by: NIHAL BASHIR, et al.
Published: (2024-04-01) -
Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
by: Felicitas E. Hengel, et al.
Published: (2025-08-01)